The Inflation Reduction Act (IRA) provides meaningful financial relief for millions of people, but there’s so much more to it than that.  

In this episode of the “Pharmacy Friends” podcast, “Prescription for change: The IRA’s impact on Pharmacy,” hear our experts talk about how Prime Therapeutics (Prime) is positioned to put people first and deliver flexible government health care programs that drive affordability and enhance the member experience. 

Maryam Tabatabai, PharmD, vice president of clinical information at Prime, hosts this episode, joined by Prime's government programs and compliance experts Jason Moore, vice president, government programs client strategy and Angela Leroux, director, operational compliance. 

“The IRA is a big change, really one of the largest changes ever to the Medicare program,” Moore said. “It is absolutely front and center in how we’re going to be looking to the future to shape how we’re going to talk to our clients.”  

“Pharmacy Friends” is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming and, most importantly, what it means to you. Listen to the full episode “Prescription for change: The IRA’s impact on Pharmacy,” on PrimeTherapeutics.com/Listen.